Conduit Pharmaceuticals Inc (CDT) Stock Price, Quote & News

Company Profile

CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has stra...

Industry: Biotechnology

Sector: Healthcare

Phone: 646 491 9132

Website: www.conduitpharma.com

Address:

4581 Tamiami Trail North, Suite 200, Naples, United States

7traderja Dec. 5 at 12:16 AM

$CDT added

0 · Reply

East_Saxon_3 Dec. 4 at 10:38 PM

$CDT Ready for the $SMX kind of rise here 😎👨‍🔬

0 · Reply

makedatbread88 Dec. 4 at 7:49 PM

$CDT another oversold low floater to watch slowly

0 · Reply

MickeyAsh Dec. 4 at 6:58 PM

$CDT Both are on 🔥

0 · Reply

max315 Dec. 4 at 6:56 PM

$CDT watch the volume over 2. 2.14 is when the scanners go off. I love being in before the newbies.

0 · Reply

max315 Dec. 4 at 6:54 PM

$CDT hmm sell now and miss the pop? Will it pop? sus climb on low volume.

0 · Reply

FireSignal Dec. 4 at 6:40 PM

Bought $CDT at 1.89

0 · Reply

max315 Dec. 4 at 6:22 PM

$CDT ready @Nevilhch ?

1 · Reply

max315 Dec. 4 at 5:43 PM

$SMX recent splits to watch $CDT ticking up, and $RUBI

0 · Reply

MickeyAsh Dec. 4 at 4:41 PM

$CDT still this and IPW. Holding. Looking for over 3.30 on CDT and over 20 on IPW

0 · Reply

CDT Equity Increases Bitcoin Holding

Oct 9, 2025, 8:00 AM EDT - 2 months ago

CDT Equity Inc. Announces Reverse Stock Split

Sep 17, 2025, 8:30 AM EDT - 2 months ago

CDT Executes Cryptocurrency Treasury Reserve Strategy

Aug 26, 2025, 8:30 AM EDT - 3 months ago

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Aug 5, 2025, 8:30 AM EDT - 4 months ago

Conduit to Change Name to CDT Equity Inc.

Jul 8, 2025, 8:30 AM EDT - 5 months ago

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Jul 7, 2025, 8:30 AM EDT - 5 months ago

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Jun 4, 2025, 8:30 AM EDT - 6 months ago

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

May 22, 2025, 8:30 AM EDT - 7 months ago

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

May 21, 2025, 8:30 AM EDT - 7 months ago

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

May 16, 2025, 8:30 AM EDT - 7 months ago

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

May 9, 2025, 8:30 AM EDT - 7 months ago

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

May 8, 2025, 8:30 AM EDT - 7 months ago

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Apr 16, 2025, 8:30 AM EDT - 8 months ago

Conduit Pharmaceuticals Announces Leadership Changes

Apr 11, 2025, 8:30 AM EDT - 8 months ago

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Mar 31, 2025, 8:30 AM EDT - 8 months ago

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Mar 19, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Mar 6, 2025, 9:35 AM EST - 9 months ago

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Feb 20, 2025, 8:00 AM EST - 10 months ago

Conduit Progresses Phase II of its AI Initiative with Sarborg

Feb 13, 2025, 8:00 AM EST - 10 months ago

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Feb 11, 2025, 9:00 AM EST - 10 months ago

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Feb 7, 2025, 8:00 AM EST - 10 months ago

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Jan 28, 2025, 5:30 AM EST - 11 months ago

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Dec 12, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Nov 21, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Nov 19, 2024, 4:30 PM EST - 1 year ago

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Nov 4, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Nov 1, 2024, 4:45 PM EDT - 1 year ago

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Aug 8, 2024, 6:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

May 22, 2024, 7:00 AM EDT - 1 year ago

AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024

AZN

May 21, 2024, 8:00 AM EDT - 1 year ago

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

Mar 19, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Mar 11, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

Jan 31, 2024, 8:30 AM EST - 2 years ago

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

Oct 11, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

Oct 11, 2023, 8:30 AM EDT - 2 years ago

ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656

Oct 4, 2023, 12:07 PM EDT - 2 years ago

Why Shares of Conduit Pharmaceuticals Are Jumping Wednesday

Sep 22, 2023, 9:01 AM EDT - 2 years ago

Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

7traderja Dec. 5 at 12:16 AM

$CDT added

0 · Reply

East_Saxon_3 Dec. 4 at 10:38 PM

$CDT Ready for the $SMX kind of rise here 😎👨‍🔬

0 · Reply

makedatbread88 Dec. 4 at 7:49 PM

$CDT another oversold low floater to watch slowly

0 · Reply

MickeyAsh Dec. 4 at 6:58 PM

$CDT Both are on 🔥

0 · Reply

max315 Dec. 4 at 6:56 PM

$CDT watch the volume over 2. 2.14 is when the scanners go off. I love being in before the newbies.

0 · Reply

max315 Dec. 4 at 6:54 PM

$CDT hmm sell now and miss the pop? Will it pop? sus climb on low volume.

0 · Reply

FireSignal Dec. 4 at 6:40 PM

Bought $CDT at 1.89

0 · Reply

max315 Dec. 4 at 6:22 PM

$CDT ready @Nevilhch ?

1 · Reply

max315 Dec. 4 at 5:43 PM

$SMX recent splits to watch $CDT ticking up, and $RUBI

0 · Reply

MickeyAsh Dec. 4 at 4:41 PM

$CDT still this and IPW. Holding. Looking for over 3.30 on CDT and over 20 on IPW

0 · Reply

max315 Dec. 4 at 4:11 PM

$CDT here comes 2

0 · Reply

max315 Dec. 4 at 4:07 PM

$CDT setting up very nice, just like last time.

0 · Reply

max315 Dec. 4 at 2:48 PM

$CDT it a

1 · Reply

Najoua233902 Dec. 3 at 5:14 PM

$CDT that was me that green candle just now in will add dips if it does .

0 · Reply

MickeyAsh Dec. 3 at 4:59 PM

$CDT this and IPW, holding both, not selling.

0 · Reply

TheBrooklynTrader Dec. 3 at 4:47 PM

$CDT he said I was crazy 😜

1 · Reply

max315 Dec. 3 at 4:46 PM

$CDT 🤔

0 · Reply

Sam201 Dec. 3 at 4:12 PM

$CDT hope you all are still accumulating. Another 2k on that drop to 1.5 ish.

1 · Reply

max315 Dec. 3 at 3:18 PM

$CDT out essentially b/e. Got in yest 1.56 scaled out like a surgeon today to not knife it. Market not good enough for these low vol guys.

0 · Reply

Nevilhch Dec. 3 at 2:47 PM

$CDT With these thieves, the only way to make money is by short selling their shares. I learned this late, but better late than never. No matter what the bullies in this chat say, if you want your money back, short sell them

1 · Reply

CW630 Dec. 3 at 2:40 PM

$CDT under 1.3 I think it goes under a buck fairly quick

1 · Reply

Nevilhch Dec. 2 at 5:09 PM

$CDT getting closer to gold every day

1 · Reply

Market Cap	5.41M
Revenue (ttm)	0.00
Net Income (ttm)	-17.80M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	109,702
Avg Vol	422,744
Day's Range	N/A - N/A
Shares Out	2.93M
Stochastic %K	5%
Beta	1.93
Analysts	Strong Buy
Price Target	N/A